ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Minnesota » Geriatric Medicine

Top Geriatric Medicine Prescribers in Minnesota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARGARET RICE MD

Geriatric Medicine

26,369

$1.3M

658
636 are 65+

3%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$49
Average prescription price

Avg: $52

DANIEL STEIN MD

Geriatric Medicine

19,775

$1.03M

739
628 are 65+

13%
patients receiving schedule two controlled substances

Avg: 11%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$52
Average prescription price

Avg: $52

LAWRENCE KERZNER MD

Geriatric Medicine

17,290

$1.1M

477
361 are 65+

11%
patients receiving schedule two controlled substances

Avg: 11%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$64
Average prescription price

Avg: $52

KENNETH ENGBERG MD

Geriatric Medicine

14,798

$778K

672
645 are 65+

11%
patients receiving schedule two controlled substances

Avg: 11%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 20%

$53
Average prescription price

Avg: $52

FLOYD KNIGHT MD

Geriatric Medicine

12,926

$715K

536
485 are 65+

8%
patients receiving schedule two controlled substances

Avg: 11%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 20%

$55
Average prescription price

Avg: $52

PAUL KUHNMUENCH MD

Geriatric Medicine

12,832

$603K

567
530 are 65+

8%
patients receiving schedule two controlled substances

Avg: 11%

10%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 20%

$47
Average prescription price

Avg: $52

OLUFEMI BANJOKO MD

Geriatric Medicine

12,132

$712K

474
449 are 65+

10%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 20%

$59
Average prescription price

Avg: $52

MARTHA MCCUSKER MD

Geriatric Medicine

10,463

$541K

577
502 are 65+

18%
patients receiving schedule two controlled substances

Avg: 11%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 20%

$52
Average prescription price

Avg: $52

MICHAEL STOCKMAN DO

Geriatric Medicine

10,269

$590K

559
526 are 65+

7%
patients receiving schedule two controlled substances

Avg: 11%

2%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 20%

$57
Average prescription price

Avg: $52

MICHAEL SPILANE MD

Geriatric Medicine

9,289

$487K

404
320 are 65+

11%
patients receiving schedule two controlled substances

Avg: 11%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 20%

$52
Average prescription price

Avg: $52

JOSEPH DENOR MD

Geriatric Medicine

9,018

$393K

467
447 are 65+

13%
patients receiving schedule two controlled substances

Avg: 11%

4%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 20%

$44
Average prescription price

Avg: $52

ROBERTA MEYERS MD

Geriatric Medicine

8,936

$547K

242
202 are 65+

16%
patients receiving schedule two controlled substances

Avg: 11%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 20%

$61
Average prescription price

Avg: $52

MRINALINI MUDKANNA M.D.

Geriatric Medicine

8,813

$395K

411
397 are 65+

4%
patients receiving schedule two controlled substances

Avg: 11%

5%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$45
Average prescription price

Avg: $52

JAMES ADAMS MD

Geriatric Medicine

7,695

$441K

441
414 are 65+

7%
patients receiving schedule two controlled substances

Avg: 11%

14%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 20%

$57
Average prescription price

Avg: $52

LISSA CHIPECO MD

Geriatric Medicine

6,584

$350K

416
384 are 65+

7%
patients receiving schedule two controlled substances

Avg: 11%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 20%

$53
Average prescription price

Avg: $52

DOUGLAS ZERBE M.D.

Geriatric Medicine

6,367

$288K

420
349 are 65+

5%
patients receiving schedule two controlled substances

Avg: 11%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 20%

$45
Average prescription price

Avg: $52

ROBERT SONNTAG MD

Geriatric Medicine

6,251

$276K

244
222 are 65+

11%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 20%

$44
Average prescription price

Avg: $52

BERNADETTE QUADLING

Geriatric Medicine

6,074

$304K

255
195 are 65+

10%
patients receiving schedule two controlled substances

Avg: 11%

7%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$50
Average prescription price

Avg: $52

ABIGAIL HOLLEY M.D.

Geriatric Medicine

5,977

$263K

276
246 are 65+

18%
patients receiving schedule two controlled substances

Avg: 11%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 20%

$44
Average prescription price

Avg: $52

ROBERT HELGREN MD

Geriatric Medicine

5,807

$249K

267
260 are 65+

29%
patients receiving schedule two controlled substances

Avg: 11%

14%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 20%

$43
Average prescription price

Avg: $52

DAVID BELL M.D.

Geriatric Medicine

5,456

$222K

337
291 are 65+

5%
patients receiving schedule two controlled substances

Avg: 11%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 20%

$41
Average prescription price

Avg: $52

PAUL TAKAHASHI M.D.

Geriatric Medicine

5,438

$246K

341
304 are 65+

5%
patients receiving schedule two controlled substances

Avg: 11%

5%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$45
Average prescription price

Avg: $52

SARAH CRANE M.D.

Geriatric Medicine

4,663

$230K

290
256 are 65+

6%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 20%

$49
Average prescription price

Avg: $52

ALVIN HOLM MD

Geriatric Medicine

4,635

$382K

348
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 20%

$82
Average prescription price

Avg: $52

DEBRA ZIMMER M.D.

Geriatric Medicine

3,865

$221K

97
86 are 65+

22%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 20%

$57
Average prescription price

Avg: $52

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank